{'fraction_non_alphanumeric': 0.03433658329800763, 'fraction_numerical': 0.01639112618341105, 'mean_word_length': 5.5441516412390195, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Co-expression of Myoepithelial and Melanocytic Features in Carcinoma Ex Pleomorphic Adenoma

The presence of melanin pigment and melanocytic markers expression have been rarely reported in salivary gland tumors. Herein, two cases of carcinoma arising in pleomorphic adenoma of the parotid gland and showing diffuse expression of myoepithelial and melanocytic markers are described. The clinical-pathological clues useful in the differential diagnosis with melanoma are discussed. In addition, a review of the pertinent literature is also proposed, discussing the pathologic mechanisms potentially involved in this phenomenon. Supplementary Information The online version of this article (10.1007/s12105-021-01299-4) contains supplementary material, which is available to authorized users.


Case#1
In April 2020, a 77-years-old man was referred to our institution for a PET-FDG documented a hyperaccumulation in the right parotid gland (SUVmax = 29), highly suspicious for malignancy. The patient had a previous history of MM of the left leg surgically removed in November 2018 (histotype: superficial spreading MM; pathological stage: pT2b N1a; molecular analysis: BRAF and NRAS wild type). An ultrasound-guided biopsy was performed and showed an atypical spindle-cell proliferation positive for S-100 and SOX10. Based on melanoma history and the immunohistochemical features of the salivary gland lesion, a diagnosis of "suspicious for MM metastasis" was rendered, and the 1 3 patient underwent total parotidectomy. Presently, six months after surgery, the patient is alive with no evidence of disease.

Case#2
In August 2015, a 63-years-old man underwent radiological work-up for the rapid onset of a left parotid gland swelling with facial nerve palsy. CT scan showed a 22 × 19 mm nodular lesion of the left parotid gland with infiltration of the facial nerve and suspicious for carcinoma; besides, multiple nodular lesions, radiologically suspicious for metastasis, were detected in the liver and both lungs. Extensive dermatological examination did not show a skin primary melanoma. A subtotal left parotidectomy with homolateral upper omohyoid lymphadenectomy was performed. At 4 months follow-up, a CT scan showed a size increase of the lungs and liver lesions; repeated second dermatologic examination did not reveal skin melanoma. The patient died of widespread metastatic disease seven months later.

and 2)
On histology, the nodule showed infiltrating margins and fascicular growth pattern. The neoplastic cells were predominantly spindle, intermixed with scattered epithelioid and multinucleated cells. Atypical mitoses were rare, in the absence of necrosis, lymph-vascular invasion and perineural infiltration. No melanin pigment was observed. The carcinomatous component gradually merged with the PA and the PA's capsule was diffusely infiltrated.
The slides of the skin MM (superficial spreading histotype, with a predominant nested growth pattern and composed of epithelioid and spindle cells) were reviewed by two pathologists (BC and CR) and compared with the salivary gland lesion. The two lesions resulted different in morphology (fascicular growth pattern with only spindle cells) and immunohistochemical profile, as the skin MM lacked cytokeratin and myoepithelial marker expression.

Case#2 (Fig. 2, Supplementary Material 3)
On histological examination, the salivary gland parenchyma was diffusely infiltrated by a diffuse, pattern-less proliferation of neoplastic cells, displaying permeative and infiltrative margins. It was composed of a mixture of highly pleomorphic, epithelioid, spindle and giant neoplastic cells.
Neoplastic cells displayed evident nucleoli and pseudonuclear inclusions. Atypical mitoses were numerous; large areas of necrosis, lymph-vascular invasion and perineural infiltration were present; no melanin pigment was observed. On close examination, a hyaline and myxoid nodular area suggestive for a pre-existing PA was detected in the central area of the tumor. None of the examined lymph nodes (total number: 35) showed metastatic deposits.

Immunohistochemistry
Focal positivity for myoepithelial (SMA, desmin, p63 and S-100) and epithelial (low molecular weight cytokeratins) markers was present. Melanocytic markers as SOX10 and MITF showed a diffuse and strong positivity, while HMB45 and MART-1 were focally present. All the remaining markers (cytokeratin 7, high molecular weight cytokeratins, BRAF V600E, synaptophysin, chromogranin, CD117, DOG-1, and CD45) resulted negative. The proliferative index, evaluated with Ki67 reached 20% in the hot-spot areas. In both cases, a final diagnosis of carcinoma ex PA with myoepithelial/melanocytic overlapping differentiation was finally rendered. Clinical-pathological data of the two cases are summarized in Table 1; all antibodies applied in the study are listed in Supplementary Material 4.

Discussion
The presented two cases of carcinoma ex PA showed immunohistochemical expression of melanocytic markers, mimicking MM and potentially representing a diagnostic challenge. In both cases, the histological diagnosis of myoepithelial/melanocytic overlapping differentiation in carcinoma ex PA was reached after complete surgical resection, based on the histological features of the entire lesions Table 1 Clinical-pathological data of Cases #1 and #2 and the complete immunohistochemical profile. Besides, BRAF V600E was negative in both cases. The presence of epithelial/myoepithelial markers allowed to exclude both metastatic and exceptionally rare primary MM of the salivary glands [12,13]. The most challenging aspect of the presented two cases and subject of numerous pathogenetic speculations is the widespread expression of multiple melanocytic markers, as well as the potential presence of melanin pigment in salivary gland tumors [2][3][4][5][6][7][8][9][10][11]. Salivary glands tumors can be "colonized" by the melanocytes resident in the salivary glands [2][3][4][5][6][7][8]. Melanocytes present in human oral mucosa and salivary glands of healthy patients can be activated and move to the adjacent tumor, injecting melanosomes in the neoplastic cells, similarly to what occurs with keratinocytes in the epidermis [2][3][4][5][6]. Melanocytic colonization can justify the aberrant expression of some melanocytic markers (HMB45 and MART-1) by salivary gland tumors [8][9][10][11]. Nevertheless, the present two cases did not show melanin pigment and/or cells with a clear-cut melanocytic morphology (large and dendritic cells, with an appearance similar to melanocytes found in the basal layer of the normal skin), but only an immunohistochemical melanocytic differentiation. In addition, positivity for markers related to melanosomes (MART-1 and HMB45) was associated with positivity for markers of melanocytic differentiation as SOX10 and MITF; furthermore, the positivity was so strong and widespread throughout the entire lesion to be difficultly explainable just by melanosomes presence in the neoplastic cells. The alternative pathogenetic theory is a myoepithelial/melanocytic overlapping differentiation, justified by a common neural crest origin and proved by numerous shared immunohistochemical markers such as S-100 [7]. Myoepithelial cells are well-known for the potential acquisition of divergent phenotypes, as epithelioid, spindle, adipocytic, clear, plasmacytoid, squamous with or without keratin [7,10,11]. Desai SS et al. reported a case of adenoid cystic carcinoma with abundant melanin in the neoplastic myoepithelial cells, with no evidence of intratumoral cells resembling dendritic melanocytes [7]. The authors interpreted this phenomenon as a demonstration that myoepithelial cells can acquire a melanocytic-like phenotype [7]. As result, the melanocytic immunophenotype and the synthesis of melanin by myoepithelial cells should be considered as an alternative "phenotypic avatar" potentially shown by these plastic cells [7]. Additional proof of the myoepithelial/melanocytic overlapping differentiation is the widespread SOX10 expression observed in salivary glands [9,10]. Ohtomo et al. reported that in normal human salivary gland tissue, SOX10 expression was observed in the nuclei of acini and both luminal and abluminal cells of intercalated ducts [10]. The same authors showed as SOX10 is expressed from the developmental stage to adulthood, associated with the presence of epithelial stem/progenitor cells from embryonic day 13.5 (E13.5) [10]. In the neoplastic counterpart, SOX10 is observed in a broad group of tumors as acinic cell carcinomas, adenoid cystic carcinomas, epithelial-myoepithelial carcinomas, myoepithelial carcinomas, basal cell adenoma and pleomorphic adenoma [9,10]. These data suggest that a broad family of salivary glands tumors, regardless of a specific lineage, derive from neural crest stem cells (SOX-10 positive) and may display a plastic and hybrid phenotype not always clearly definable [10]. For this reason, Ohtomo et al. proposed a revolutionary classification of salivary glands neoplasia in SOX10 + tumors (originating from neural crest stem cells) and SOX10 -ones (alternative origin) [10]. Melanocytic differentiation has been reported also in metaplastic breast carcinoma and rare examples of soft tissue tumors with bi or multi-directional differentiation [14][15][16]. It remains to be determined whether this apparently paradoxical differentiation is the result of the transformation of a cancer stem cell (histogenesis theory) rather than a trans-melanocytic differentiation occurring as a late-step change (dedifferentiation theory) [14][15][16]. The cases of salivary gland tumors with melanin pigment and/or melanocytic phenotype reported in the literature are too few to obtain data on the possible prognostic impact of the myoepithelial/ melanocytic overlapping differentiation [2][3][4][5][6][7][8][9][10][11]. The reported cases were different in histological subtypes and AJCC clinical-pathological stages, which does not allow to obtain easily comparable data on the possible prognostic impact of this rare and intriguing phenomenon [2][3][4][5][6][7][8][9][10][11]. Carcinoma ex PA could show a broad range of histological features and, as consequence, of clinical aggressivity and prognosis (Case#1 had a low-grade malignant component and a very short follow-up; Case#2 had a pleomorphic and high-grade malignant component and the patient died of widespread metastatic disease 7 months after the diagnosis); besides, Case#2 showed at onset multiple lesions in liver and lungs, radiologically suspicious for metastasis (IV AJCC clinical stage). As result, the present cases do not add specific prognostic information as we think that the different histology and AJCC clinical stage could justify the clinical course of the two patients, regardless of the co-expression of myoepithelial and melanocytic features. Future studies are needed to clarify if this this aberrant melanocytic phenotype could have clinical and prognostic relevance.

Conclusions
Herein, two cases of carcinoma ex PA with myoepithelial/ melanocytic overlapping differentiation of the parotid gland are presented, together with the clinical-pathological features helpful in the differential diagnosis with MM. Possible pathogenic theories justifying this curious and diagnostic challenging aspect are also discussed.

Author Contributions
All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by CR, BC and TB. EP and OP provided the clinical information. The first draft of the manuscript was written by CR and MPF; all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
Funding Open Access funding provided by Alma Mater Studiorum -Università di Bologna.
Data Availability All data generated and/or analyzed during this study are included in this published article [and its supplementary information files].

Compliance with Ethical Standards
Conflict of interest Maria Pia Foschini received grants from Roche, Devicor Mammotome as support for courses organization and participation; from MSD and Biocartis as speaker fee. The remaining Authors declare that they have no conflict of interest related to the present work.
Ethical Approval All procedures performed in this study and involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. According to the Italian legislation, etichs approval by ethics committee is not required for this type of study (Case Report). Authors are responsible for correctness of the statements provided in the manuscript.

Consent to Participate
Informed consent to participate was obtained from all individual participants included in the study (by Patient #1 and by the wife of Patient #2).

Consent to Publish
Although this paper does not contain data that can identify the single patients and therefore "consent to publish" is not needed, the "informed consent to publish" was obtained from all individual participants included in the study (by Patient #1 and by the wife of Patient #2).
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creat iveco mmons .org/licen ses/by/4.0/.